167 related articles for article (PubMed ID: 8418582)
1. Antipsychotic agents: a review.
Dilsaver SC
Am Fam Physician; 1993 Jan; 47(1):199-204. PubMed ID: 8418582
[TBL] [Abstract][Full Text] [Related]
2. Psychologists and psychoactive drugs.
Murray JB
Genet Psychol Monogr; 1978 Nov; 98(Second Half):281-323. PubMed ID: 31317
[TBL] [Abstract][Full Text] [Related]
3. Legal liability with psychotropic drug use: extrapyramidal syndromes and tardive dyskinesia.
Mills MJ; Eth S
J Clin Psychiatry; 1987 Sep; 48 Suppl():28-33. PubMed ID: 3624218
[TBL] [Abstract][Full Text] [Related]
4. Movement disorders with neuroleptic drug treatment.
Tarsy D
Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
[TBL] [Abstract][Full Text] [Related]
5. [Iatrogenic extrapyramidal disorders].
Ludin HP
Schweiz Med Wochenschr; 1990 Jun; 120(23):855-8. PubMed ID: 1972812
[TBL] [Abstract][Full Text] [Related]
6. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
7. [Neuroleptic-induced movement disorders: historical perspectives].
Wolf MA; Yassa R; Llorca PM
Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
[TBL] [Abstract][Full Text] [Related]
8. Neurologic complications of drugs. Tardive dyskinesias, neuroleptic malignant syndrome, and cocaine-related syndromes.
Rodnitzky RL; Keyser DL
Psychiatr Clin North Am; 1992 Jun; 15(2):491-510. PubMed ID: 1351285
[TBL] [Abstract][Full Text] [Related]
9. Potential adverse effects of discontinuing psychotropic drugs. Part 3: Antipsychotic, dopaminergic, and mood-stabilizing drugs.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2010 Aug; 48(8):11-4. PubMed ID: 20669865
[TBL] [Abstract][Full Text] [Related]
10. A pharmacological and theoretical comparison of high and low potency neuroleptics.
Zavodnick S
J Clin Psychiatry; 1978 Apr; 39(4):332-6. PubMed ID: 24619
[TBL] [Abstract][Full Text] [Related]
11. Psychiatric iatrogenic disorders.
Siomopoulos V
Am Fam Physician; 1986 Oct; 34(4):111-6. PubMed ID: 3766357
[TBL] [Abstract][Full Text] [Related]
12. [Late extrapyramidal hyperkinesis and neuroleptic withdrawal dyskinesia. Practical problems].
Hoffmann C; Faust V
Fortschr Med; 1983 Mar; 101(11):470-6. PubMed ID: 6133824
[TBL] [Abstract][Full Text] [Related]
13. Some adverse effects of antipsychotics: prevention and treatment.
Lader M
J Clin Psychiatry; 1999; 60 Suppl 12():18-21. PubMed ID: 10372605
[TBL] [Abstract][Full Text] [Related]
14. Use and abuse of anticholinergic drugs in psychiatry.
Gelenberg AJ
Hillside J Clin Psychiatry; 1984; 6(2):148-55. PubMed ID: 6396187
[TBL] [Abstract][Full Text] [Related]
15. Managing tardive dyskinesia.
Casey DE
J Clin Psychiatry; 1978 Oct; 39(10):748-53. PubMed ID: 30759
[TBL] [Abstract][Full Text] [Related]
16. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic-induced supersensitivity psychosis, the "hump course," and tardive dyskinesia.
Chovinard G; Jones B
J Clin Psychopharmacol; 1982 Apr; 2(2):143-4. PubMed ID: 6122695
[No Abstract] [Full Text] [Related]
18. Unexpected and prolonged akinesia: a case report.
Fink EB
J Clin Psychiatry; 1978 Nov; 39(11):817-8. PubMed ID: 31353
[TBL] [Abstract][Full Text] [Related]
19. Psychotropic discontinuation symptoms: a case of withdrawal neuroleptic malignant syndrome.
Stonecipher A; Galang R; Black J
Gen Hosp Psychiatry; 2006; 28(6):541-3. PubMed ID: 17088172
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of antipsychotic drug-induced movement disorders.
Casey DE
J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
